Cutaneous Squamous Cell Carcinoma Clinical Trials

107 clinical trials for Cutaneous Squamous Cell Carcinoma across international registries, including 35 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer — RECRUITING · PHASE1
• A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors — RECRUITING · PHASE1
• Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy — RECRUITING · PHASE4
• Testing Whether Skin Cancer Has Spread to Nearby Lymph Nodes — RECRUITING · NA
• A Phase 2 study of intratumoral administration of L19IL2/L19TNF in locally advanced Cutaneous Squamous Cell Carcinoma patients progressing on or intolerant to systemic treatment. — RECRUITING · PHASE2
• A Study of IDP-001 in Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma — RECRUITING · PHASE2
• Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma — RECRUITING · PHASE3
• Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma — RECRUITING · PHASE1
• MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors — RECRUITING · PHASE1
• Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma — RECRUITING · PHASE2
• A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients — RECRUITING · PHASE1
• Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment. — RECRUITING
• MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer — RECRUITING · PHASE2
• Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence — RECRUITING · PHASE3
• Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) — RECRUITING · PHASE1
• A Study of VET3-TGI in Patients With Solid Tumors — RECRUITING · PHASE1
• Cutaneous Squamous Cell Carcinoma Staging Study — RECRUITING
• ctDNA in Cutaneous Squamous Cell Carcinoma — RECRUITING
• Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors — RECRUITING · PHASE1
• TIL Therapy in cSCC and MCC — RECRUITING · PHASE2
• Ex Vivo Cutaneous SCC — RECRUITING · NA
• Thermotherapy in Addition to SOC Palliative Radiotherapy — RECRUITING · NA
• Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma — RECRUITING
• A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision — RECRUITING · PHASE1
• Personalised Immunotherapy Platform — RECRUITING
• Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab. — RECRUITING
• Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors — RECRUITING · PHASE1
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck — RECRUITING · NA
• Towards Cure Via Only Ultra-short ICB in CSCC — RECRUITING · PHASE2
• Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study — RECRUITING
• Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC — RECRUITING
• Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis) — RECRUITING · PHASE2
• B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers — RECRUITING
• A Phase II, Open-Label, Single-Arm, Multicentre Study of Immunotherapy and non-invasive response evaluation in cutaneous squamous cell carcinoma as an organ preservation strategy: a proof of concept clinical study and translational correlates - INCEPT — NOT_YET_RECRUITING · PHASE2
• D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab — NOT_YET_RECRUITING
• Towards organ preservation and cure via immunotherapy in cutaneous squamous cell carcinoma patients, normally undergoing extensive curative surgery and radiotherapy: Matisse-2 — TERMINATED · PHASE2
• Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma — NOT_YET_RECRUITING · PHASE2
• A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ADJUVANT CEMIPLIMAB VERSUS PLACEBO AFTER SURGERY AND RADIATION THERAPY IN PATIENTS WITH HIGH RISK CUTANEOUS SQUAMOUS CELL CARCINOMA — TERMINATED · PHASE3
• A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma — WITHDRAWN · PHASE1
• Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions — COMPLETED · NA
• In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer — TERMINATED · PHASE2
• Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications — TERMINATED · PHASE1
• Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers — ACTIVE_NOT_RECRUITING
• A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Flash Radiotherapy for Skin Cancer — NOT_YET_RECRUITING · PHASE2
• Mechanisms of Resistance to anti-PD-1 Therapy in cutaneous Squamous Cell Carcinomas: Impact of Tumor Cell Plasticity on Promoting Myeloid Suppressor Cell Infiltration. A phase II single arm, unicenter study of cemiplimab in patients with locally advanced cSCCs. — NOT_YET_RECRUITING · PHASE2
• FLASH Radiotherapy for Skin Cancer — ACTIVE_NOT_RECRUITING · NA

Refine this search